Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Clinical Effectiveness & Safety LV009, an in Vivo CAR-T for the Treatment of Hematologic Cancers, Auto-immune Diseases & HLA/ AAV Sensitization.

NCT07873476 is registered in ClinicalTrials.gov with Healthy Malaysia Association as lead sponsor.

NCT NCT07873476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07873476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Clinical Effectiveness & Safety LV009, an in Vivo CAR-T for the Treatment of Hematologic Cancers, Auto-immune Diseases & HLA/ AAV Sensitization.
Lead sponsor
Healthy Malaysia Association
Phase
Observational
Overall status
Not yet recruiting
Start date
October 28, 2026
Completion date
December 31, 2031
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

auto-immune diseases, hematologic cancers, hla/aav sensitization